[HTML][HTML] The Discovery of inhibitors of the SARS-CoV-2 S protein through computational drug repurposing

AI Avilés-Alía, J Zulaica, JJ Perez… - Computers in biology …, 2024 - Elsevier
SARS-CoV-2 must bind its principal receptor, ACE2, on the target cell to initiate infection.
This interaction is largely driven by the receptor binding domain (RBD) of the viral Spike (S) …

Assessment of the bound conformation of bombesin to the BB1 and BB2 receptors

G Vila-Julià, J Rubio-Martinez, JJ Perez - International journal of biological …, 2024 - Elsevier
Bombesin is an endogenous peptide involved in a wide spectrum of physiological activities
ranging from satiety, control of circadian rhythm and thermoregulation in the central nervous …

Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation

MN Peralta-Moreno, Y Mena, D Ortega-Alarcon… - International Journal of …, 2024 - mdpi.com
The development of specific antiviral therapies targeting SARS-CoV-2 remains fundamental
because of the continued high incidence of COVID-19 and limited accessibility to antivirals …

On the importance for drug discovery of a transnational Latin American database of natural compound structures

TM Thomson - Frontiers in Pharmacology, 2023 - frontiersin.org
Drug development is a complex, risky, expensive and time-consuming process that requires
the accurate execution of multiple stages, from identification and selection of collections of …

Assessment of the bound conformation of Bombesin to the BB1 and BB2 Receptors

G Vila-Julià, J Rubio-Martinez, JJ Perez - bioRxiv, 2023 - biorxiv.org
Bombesin is an endogenous peptide involved in a wide spectrum of physiological activities
ranging from satiety, control of circadian rhythm and thermoregulation in the central nervous …